Coronavirus disease (COVID-19) is an infectious disease caused by the coronavirus SARS-CoV-2. Here we have collected APR news related to the COVID-19 pandemic, vaccination efforts and emerging treatments.
Thursday, September 23, 2021
Valneva, a specialty vaccine company, announced that it has commenced recruitment of adolescents in its pivotal Phase 3 Clinical Trial (VLA2001-301, “Cov-Compare”) for its inactivated COVID-19 vaccine...
read more
Wednesday, September 22, 2021
Pfizer and BioNTech announced results from a Phase 2/3 trial showing a favorable safety profile and robust neutralizing antibody responses in children 5 to 11 years of age using a two-dose regimen of ...
read more
Wednesday, September 22, 2021
Pfizer and BioNTech that the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to recommend the FDA grant Emergency Use Authorization (EUA) for a booster dose ...
read more
Wednesday, September 22, 2021
Pfizer and BioNTech announced plans to expand their agreement with the U.S. government by providing an additional 500 million doses of the companies’ COVID-19 vaccine at a not-for-profit price for ...
read more
Monday, September 20, 2021
The FDA revised the emergency use authorization (EUA) for bamlanivimab and etesevimab, administered together, to include emergency use as post-exposure prophylaxis (prevention) for COVID-19 in adults ...
read more
Wednesday, September 15, 2021
Eli Lilly and Company announced an additional purchase by the U.S. government for its neutralizing antibody therapies authorized for emergency use as a treatment for COVID-19. As part of the agreement...
read more
Monday, September 13, 2021
Humanigen, a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ announced the U.S. FDA has declined its request for emergency...
read more
Monday, September 13, 2021
Everest Medicines Limited announced two separate definitive agreements ("Agreements") with Providence Therapeutics Holdings Inc. ("Providence"), a clinical stage biotechnology company developing ...
read more
Monday, September 13, 2021
Navrogen, Inc., a privately held preclinical biotechnology company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with researchers at The United ...
read more
Wednesday, September 08, 2021
National Resilience, a company seeking to build the world’s most advanced biopharmaceutical manufacturing ecosystem, and Moderna announced an agreement to manufacture drug substance for the Moderna ...
read more
Friday, September 03, 2021
Thermo Fisher Scientific Inc., the world leader in serving science, announced a $192.5 million contract award from the U.S. Department of Defense (DoD) to ensure reliable domestic production of ...
read more
Friday, September 03, 2021
AstraZeneca and the European Commission have reached an agreement that ends legal proceedings over the execution of the Advance Purchase Agreement for the delivery of the COVID-19 vaccine Vaxzevria (...
read more
Thursday, September 02, 2021
Aquavit Pharmaceuticals, Inc., a biotechnology company focused on the development of a first-of-its-kind microchannel drug delivery technology, has received USPTO's Fast-Track Prioritized Examination ...
read more
Wednesday, September 01, 2021
Merck and Ridgeback Biotherapeutics announced the initiation of the Phase 3 MOVe-AHEAD clinical trial to evaluate molnupiravir, an investigational oral antiviral therapeutic, for the prevention of ...
read more
SignalRx Pharmaceuticals Inc., Crystec Ltd., and ADYA Consulting SAGL announced a new collaboration to develop an inhaled dry powder formulation of SF2523 for the treatment of pulmonary fibrosis, lung...
read more